OCUL

Ocular Therapeutix Inc

NASDAQ

Add Alert

OCUL

Ocular Therapeutix Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

Whalatane

04/06/24 4:41 PM

Post #234

OCUL. P2 data 4/5/24
REUTERS
10:03 AM ET 04/06/2024
April 6 (Reuters) - Ocular Therapeutix Inc (OCUL):
* OCULAR THERAPEUTIX™ ANNOUNCES POSITIVE PHASE 2 PAXTRAVA™ GLAUCOMA DATA AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY 2024 ANNUAL MEETING
* OCULAR THERAPEUTIX INC (OCUL) - GENERALLY WELL TOLERATED WITH NO IMPACT ON CORNEAL HEALTH OBSERVED
* OCULAR THERAPEUTIX INC (OCUL) - CLINICALLY MEANINGFUL MEAN IOP REDUCTION OF ABOUT 24-30% FROM BASELINE OBSERVED OVER SIX MONTHS Source text for Eikon: Further company coverage:

Kiwi

Monksdream PremiumMember

03/30/24 1:25 PM

Post #233

OCUL under $10

Monksdream PremiumMember

03/10/24 11:03 AM

Post #232

OCUL 10Q due March 11

glenn1919

12/09/23 10:00 AM

Post #231

Re: #229: @glenn1919 - OCUL..........................................https://stockcharts.com/h-sc/ui?s=

OCUL....................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783

trendzone

02/14/23 4:02 PM

Post #230

Tard sells $6.00 call option at $0.15 at the close,apparently they were born yesterday.

glenn1919

02/14/23 12:30 PM

Post #229

OCUL..........................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783

trendzone

02/13/23 1:52 PM

Post #228

Clueless fool sells $6.00 call option at $0.10 when they were just trading at $0.30,with the big rally going on in the stock today, what a total fool they are.

cuggegrosse Free

02/06/23 4:21 PM

Post #227

I chose OCUL to invest in because the market conditions should not effect the PPS(much),plus I can sell covered calls and make some monthly cash,besides they have products that are in demand !!!!

Bullish

cuggegrosse Free

01/19/23 2:52 PM

Post #226

Re: #225: @Tzr250rg - Ask is super thin wont take much to

Yes I have noticed that

Bullish

Tzr250rg

01/19/23 2:51 PM

Post #225

Re: #224: @cuggegrosse - My eye doctor says Dextenza is a very

Ask is super thin wont take much to move. GLTUA

cuggegrosse Free

01/17/23 2:23 PM

Post #224

My eye doctor says Dextenza is a very good drug and he raccomends it !!!!!

Bullish

cuggegrosse Free

01/17/23 12:18 PM

Post #223

Re: #221: @spotonge - boys need to wake up

DEXTENZA is doing very,very well,great revs expected in 2023

Bullish

cuggegrosse Free

01/15/23 1:58 PM

Post #222

Re: #218: @oxnous - With the aging population, eye care is becoming

This company could go to $8.00 very eassy

Bullish

spotonge

09/29/22 6:06 PM

Post #221

boys need to wake up

biotechslayr Free

09/12/22 7:36 AM

Post #220

Is anyone at all following OCUL into the end of the months binary? TKI data could be a game changer. Total TAM is ridiculous (look at REGN mcap!)

oxnous

06/23/21 4:27 PM

Post #219

Re: #214: @TheFinalCD - OCUL 10.87 NEW HIGH OF DAY

OCUL --charting

oxnous

06/08/21 11:46 AM

Post #218

Re: #215: @whytestocks - Breaking News: $OCUL Ocular Therapeutix(TM) Announces Topline Phase

With the aging population, eye care is becoming an increasing concern. Dry eye, glaucoma, macular degeneration etc. will be expanding market sub sectors

ClayTrader Free

04/29/21 4:57 PM

Post #217

* * $OCUL Video Chart 04-29-2021 * *

Link to Video - click here to watch the technical chart video

whytestocks Free

11/04/20 2:30 PM

Post #216

Just In: $OCUL Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that its application for the creation of a Category I Current Procedural Ter...

In case you are interested OCUL - Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts

whytestocks Free

10/08/20 8:15 AM

Post #215

Breaking News: $OCUL Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI

OTX-CSI demonstrates improvement in signs and symptoms of Dry Eye Disease Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the ey...

Got this from OCUL - Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI

TheFinalCD PremiumMember

10/07/20 3:07 PM

Post #214

Re: #213: @whytestocks - Just In: $OCUL Ocular Therapeutix Announces Preliminary Net

OCUL 10.87 NEW HIGH OF DAY

whytestocks Free

10/07/20 12:30 PM

Post #213

Just In: $OCUL Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported preliminary, unaudited net product revenue for the third quarter ended Septe...

Find out more OCUL - Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter

now invest Free

06/08/20 1:47 PM

Post #212

Thus far OCUL is trading nicely!!

ClayTrader Free

05/22/20 4:33 PM

Post #211

* * $OCUL Video Chart 05-22-2020 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

03/04/20 5:16 PM

Post #210

* * $OCUL Video Chart 03-04-2020 * *

Link to Video - click here to watch the technical chart video

edwardport Free

02/09/20 12:33 AM

Post #209

near term 10% projected increase in market price

closed on 2/7/20 @ $5.21

ClayTrader Free

02/07/20 6:05 PM

Post #208

* * $OCUL Video Chart 02-07-2020 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

01/03/20 4:13 PM

Post #207

* * $OCUL Video Chart 01-03-2020 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

11/29/19 2:20 PM

Post #206

* * $OCUL Video Chart 11-29-2019 * *

Link to Video - click here to watch the technical chart video

TFMG

07/30/19 11:43 PM

Post #205

OCUL - POSSIBLE 25% TREND MOVE ON THE DAILY

Ocular Therapeutix , Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

SHORT INTEREST
8.24M 07/15/19

P/E Current
-2.78

P/E Ratio (with extraordinary items)
-2.92

Average Recommendation: OVERWEIGHT

Average Target Price: 9.67

tste9

07/26/19 6:44 PM

Post #204

Re: #202: @whytestocks - News: $OCUL Ocular Therapeutix(TM) Announces Early Assignment of

Great news! BUT, hoped for more volume price etc. wow
GLA

ClayTrader Free

07/26/19 6:03 PM

Post #203

* * $OCUL Video Chart 07-26-2019 * *

Link to Video - click here to watch the technical chart video

whytestocks Free

07/26/19 9:50 AM

Post #202

News: $OCUL Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a ...

Got this from Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services

smallbio

07/20/19 2:16 PM

Post #201

Is DEXTENZA currently only targeting medicare patients, as there is no private insurance company will reimburse the cost?

tste9

07/19/19 7:19 PM

Post #200

Re: #198: @whytestocks - News: $OCUL Ocular Therapeutix(TM) Announces Commercial Launch of

What is up with this little piggy, lately! #&*#@*

tste9

07/13/19 12:02 PM

Post #199

Re: #198: @whytestocks - News: $OCUL Ocular Therapeutix(TM) Announces Commercial Launch of

Great news thanks for post. Do you know of any web site that posts OCUL sales per week. Thank you. GL

whytestocks Free

07/01/19 11:30 AM

Post #198

News: $OCUL Ocular Therapeutix(TM) Announces Commercial Launch of DEXTENZA® (dexamethasone intracanalicular insert) 0.4 mg for Ophthalmic Use in the United States

Pass-through payment status and C-code from the Centers for Medicare and Medicaid Services (CMS) now active Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and ...

In case you are interested https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-commercial-launch-of-dextenza-x-8439742.html

swingingRichard Free

06/23/19 9:46 AM

Post #197

Re: #196: @tste9 - Shorts ease out as usual. criminal how shorts

Shorted 10,000 shares. Looking good.

tste9

06/21/19 5:58 PM

Post #196

Shorts ease out as usual. criminal how shorts manipulate SP then just slither out unharmed. GLA

tste9

06/21/19 5:55 PM

Post #195

Re: #193: @whytestocks - News: $OCUL Ocular Therapeutix(TM) Announces FDA Approval of

YEA BABY!

ClayTrader Free

06/21/19 5:14 PM

Post #194

* * $OCUL Video Chart 06-21-2019 * *

Link to Video - click here to watch the technical chart video

whytestocks Free

06/21/19 9:50 AM

Post #193

News: $OCUL Ocular Therapeutix(TM) Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (0.4 Dexamethasone Intracanalicular Insert for Ophthalmic Use) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

DEXTENZA ® Now Approved for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases...

Find out more https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-fda-approval-of-supplemental-new-drug-application-snda-for-dextenza-xae-0-4-dexamethasone-intracanalicular-insert-for-ophthalmic-use-for-the-treatment-of-ocular-inflammation-following-ophthalmic-surgery-8394606.html

ClayTrader Free

06/11/19 5:48 PM

Post #192

* * $OCUL Video Chart 06-11-2019 * *

Link to Video - click here to watch the technical chart video

Tzr250rg

06/05/19 1:46 PM

Post #191

Re: #190: @whytestocks - News: $OCUL Ocular Therapeutix(TM) Announces Receipt of C-Code

low volume today

whytestocks Free

05/29/19 2:20 PM

Post #190

News: $OCUL Ocular Therapeutix(TM) Announces Receipt of C-Code and Pass-Through Payment Status for DEXTENZA®

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has approved t...

Got this from https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-receipt-of-c-code-and-pass-through-payment-status-for-dextenza-xae--8261962.html

ClayTrader Free

05/21/19 6:14 PM

Post #189

* * $OCUL Video Chart 05-21-2019 * *

Link to Video - click here to watch the technical chart video

now invest Free

04/25/19 10:42 PM

Post #188

Re: #185: @RickieK - Hellooooo is there anyone here

Stopped in to see anything up.... oh well...

RolandDoe

04/23/19 11:01 PM

Post #187

Hardly

Rakbors

04/23/19 1:59 PM

Post #186

Re: #185: @RickieK - Hellooooo is there anyone here

RickieK

04/15/19 7:55 PM

Post #185

Re: #184: @now invest - Thought there would be more messages here..... been

Hellooooo is there anyone here

Older

Ocular Therapeutix Inc (OCUL)

Followers	34	Posters	70
Posts (Today)	0	Posts (Total)	234
Created	05/16/15	Type	Free
Moderators

Ocular Therapeutix, Inc. 34 Crosby Drive Suite 105 Bedford, MA 01730 United States Phone: 781-357-4000 Fax: 781-357-4001 Website: http://www.ocutx.com Watchlist 26.27 Up 4.31(19.63%) May 15, 4:00PM EDT Add to Portfolio Profile Get Profile for: Ocular Therapeutix, Inc. 34 Crosby Drive Suite 105 Bedford, MA 01730 United States - Map Phone: 781-357-4000 Fax: 781-357-4001 Website: http://www.ocutx.com Details Index Membership: N/A Sector: Healthcare Industry: Biotechnology Full Time Employees: 74 Business Summary Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for eye diseases and conditions using its proprietary hydrogel platform technology in the United States. It markets ReSure Sealant, a topical liquid hydrogel that creates a sealant to prevent post-surgical leakage from clear corneal incisions during cataract surgery. The company is involved in developing OTX-DP that is in Phase III clinical trials for post-surgical ocular inflammation and pain; and is in Phase II clinical trials for the treatment of inflammatory dry eye disease, as well as that has completed Phase II clinical trials for the treatment of allergic conjunctivitis. It is also developing OTX-TP, which is in Phase IIb clinical trials for glaucoma and ocular hypertension; OTX-MP product candidate that has completed Phase I clinical trials for the treatment of ocular infection indication; and Anti-VEGF hydrogel depot, an injectable hydrogel depot that is in preclinical studies. Ocular Therapeutix, Inc. was founded in 2006 and is headquartered in Bedford, Massachusetts.